Palvella Therapeutics, Inc. (PVLA)
123.46
+3.08
(+2.56%)
USD |
NASDAQ |
Apr 02, 16:00
123.21
-0.25
(-0.20%)
After-Hours: 20:00
Palvella Therapeutics EPS Diluted (Quarterly) : -1.082 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 2.119 |
| Gossamer Bio, Inc. | -0.2085 |
| Agenus, Inc. | -0.301 |
| Novavax, Inc. | 0.1061 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.71M |
| Total Expenses (Quarterly) | 12.71M |
| Enterprise Value | 1.728B |
| Earnings Yield | -3.00% |
| Normalized Earnings Yield | -2.972 |